Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
Petrice M. Cogswell(Mayo Clinic), Tammie L.S. Benzinger(Washington University in St. Louis), Tina Young Poussaint(Seattle Children's Hospital), Jody Tanabe(University of Colorado Anschutz Medical Campus), Clifford R. Jack(Mayo Clinic), Gloria Chiang(Mayo Clinic), Lawrence Tanenbaum(Icahn School of Medicine at Mount Sinai), Vijay K. Ramanan(Mayo Clinic in Arizona), Trevor Andrews(Mayo Clinic), Cyrus A. Raji(Washington University in St. Louis), Ana M. Franceschi(University at Buffalo, State University of New York), Jay J. Pillai(Johns Hopkins University), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Marc Benayoun(Mayo Clinic), Jerome Barakos(Sutter Health), Greg Zaharchuk(Mayo Clinic), Fang Yu(Mayo Clinic), Christopher T. Whitlow(University of Nottingham), Michael Zeinah(Mayo Clinic), Suzie Bash(Mayo Clinic)
Cited by 69
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k